Full name
A Phase 3, 24-week, Randomized, Double-blind, Parallel-group Bayesian Dynamic Borrowing Study Comparing the Efficacy, Safety, Tolerability and Pharmacokinetics of FF/UMEC/VI With FF/VI in 12-17-year-old Participants With Inadequately Controlled Asthma on Stable Maintenance Therapy With ICS/LABA
NCT Number
NCT05757102
Geography
US
Non-US
Locations
Argentina, Australia, Chile, Republic of Korea, Mexico, Turkey, United States
Primary Endpoints
Change from baseline in trough forced expiratory volume in 1 second (FEV1) (Liters) at Week 24
External Link
https://clinicaltrials.gov/study/NCT05757102
Order
1
Disease
Version
Phase
3